8-K: Avinger, Inc. Announces Assignment for the Benefit of Creditors and Executive Departures

Avinger, Inc. has entered into a general assignment for the benefit of creditors, resulting in the termination of key executives and resignations of board members.

Summary

• Avinger, Inc. announced that it has entered into a general assignment for the benefit of creditors.
• The decision was made after the stockholders approved the assignment and a subsequent voluntary dissolution and liquidation.
• The company's Board of Directors determined that the assignment was in the best interest of the company and its stockholders.
• The company entered into an Assignment Agreement with Avinger (assignment for the benefit of creditors), LLC on February 10, 2025, transferring substantially all of its assets.
• In connection with the assignment, Moss Adams LLP terminated its engagement as the company's independent registered public accounting firm.
• The company terminated the employment of Himanshu Patel (Chief Technology Officer), Jeffrey M. Soinski (Chief Executive Officer), and Nabeel Subainati (Vice President, Finance).
• Each departing executive entered into a Separation Agreement and Release, receiving a lump sum payment equal to two weeks of their base salary.
• Jeffrey M. Soinski, James G. Cullen, James B. McElwee, Tamara N. Elias, and Jonathon Zhong Zhao resigned from the Board of Directors and all committees, effective February 10, 2025.
• Holders of Series E, Series F, and Series H preferred stock consented to the Assignment on February 10, 2025.

Sentiment

Score: 1

Explanation: The document indicates a complete failure of the business, with assignment for the benefit of creditors, termination of key staff and dissolution of the board. This is a highly negative outcome.

Positives

• The company is providing severance payments to the terminated executives.

Negatives

• The company has entered into an assignment for the benefit of creditors, indicating severe financial distress.
• Key executives and board members have departed, leaving the company without leadership.
• The company's independent auditor has terminated its engagement.
• The company's financial statements for the fiscal years ended December 31, 2023, and December 31, 2022, expressed substantial doubt about the company's ability to continue as a going concern.

Risks

• The assignment for the benefit of creditors may not result in sufficient funds to satisfy all creditor claims.
• The company's assets may be subject to restrictions on use or transfer, potentially hindering the assignment process.
• The company faces potential litigation or claims arising from the termination of employees and the assignment of assets.
• There is a risk of further damages or claims related to the unauthorized use or transfer of assets, including intellectual property.

Future Outlook

The company will transfer all or substantially all of its assets to the Assignee, who will then liquidate the assets and distribute the proceeds to creditors.

Industry Context

This announcement reflects significant financial distress for Avinger, Inc., a medical device company, and is indicative of challenges faced by smaller companies in the competitive medical technology market. Similar situations have occurred with companies like Hansen Medical, which was acquired after facing financial difficulties, and FlowCardia, which also underwent restructuring.

Comparison to Industry Standards

• Avinger's situation can be compared to other small-cap medical device companies that have struggled to achieve profitability and market penetration.
• Companies like Hansen Medical faced similar challenges before being acquired by Auris Surgical Robotics.
• FlowCardia, a developer of cardiovascular devices, also underwent restructuring due to financial difficulties.
• These examples highlight the competitive pressures and capital-intensive nature of the medical device industry, where smaller companies often face challenges in scaling up and achieving sustainable growth.

Management Changes

Stakeholder Impact

• Shareholders will likely experience a significant loss of investment.
• Employees have been terminated, resulting in job losses.
• Creditors face uncertainty regarding the recovery of outstanding debts.
• Customers and suppliers may be affected by the disruption of the company's operations.

Next Steps

• The Assignee will take control of the company's assets and begin the liquidation process.
• Creditors will file claims to recover outstanding debts.
• The company will proceed with voluntary dissolution and liquidation pursuant to a plan of dissolution.

Key Dates